Stock Screener App

Gratuito -

Installare

Drug Manufacturers - General

25.29

0.04% 0.010

after-market

Dopo l'orario di chiusura: 25.29

Pfizer Inc (PFE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché PFE Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Pfizer Inc Borsa (PFE) Ultime notizie

Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga

What Could Rocket Pfizer Stock to New Heights - Trefis

Setup Watch: Why Pfizer Inc. stock is favored by top institutionsQuarterly Risk Review & Weekly High Return Forecasts - ulpravda.ru

Citi Keeps Their Hold Rating on Pfizer (PFE) - The Globe and Mail

What margin trends mean for Pfizer Inc. stockExit Point & Fast Moving Stock Watchlists - ulpravda.ru

Pfizer Turns To AI Where Drug Risk Is Highest - TradingView — Track All Markets

Pfizer Partners with Boltz to Use AI in Drug Discovery - TradingView — Track All Markets

Want Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks - Finviz

How Pfizer Inc. stock performs in high volatility marketsWeekly Profit Summary & Momentum Based Trading Ideas - ulpravda.ru

Boltz and Pfizer Announce Strategic Collaboration to Develop and Deploy Biomolecular Ai Foundation Models - MarketScreener

Pfizer stock price today: PFE ticks up after 340B court block as drug-pricing scrutiny returns - TechStock²

Pfizer, Boltz Launch Collaboration to Develop Biomolecular AI Foundation Models - MarketScreener

Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment - Finviz

Boltz and Pfizer Announce Strategic Collaboration to Develop and Deploy State-of-the-Art Biomolecular AI Foundation Models - PR Newswire

PFIZER INC : Berenberg remains Neutral - MarketScreener

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity - Business Wire

Does Pfizer (PFE) Offer Long Term Value After A 36% Three Year Share Price Slide - simplywall.st

Pfizer (NYSE:PFE) Has Announced A Dividend Of $0.43 - simplywall.st

Pfizer's (NYSE:PFE) Dividend Will Be $0.43 - Yahoo Finance

Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026? - Nasdaq

Pneumococcal Vaccines Market to Boom Worldwide By 2026-2033 | - openPR.com

Is Pfizer Inc PFE stock undervalued historicallyQuarterly Earnings Report & Proven Capital Preservation Tips - moha.gov.vn

Thousands Sue Pfizer Over Claims That Birth Control Caused Brain Tumors - iHeart

PFIZER INC : UBS withdraws its Sell rating - MarketScreener

Alert from law firm on Pfizer Depo-Provera MDL trial date withdrawn - MarketScreener

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio - Bluefield Daily Telegraph

This Could Be Key to Pfizer's Turnaround in 2026 - Finviz

Bayer takes Pfizer and BioNTech to court over COVID vaccines - MarketScreener

Pfizer’s Scottish RSV Maternal Vaccine Study: What Investors Should Watch - TipRanks

Pfizer's Gandsman Takes Zeno Post - O'Dwyer's PR

Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk - ts2.tech

Vitiligo Market Set for Robust Expansion Through 2034, DelveInsight Reports | Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotech - The Globe and Mail

Pfizer needs more than obesity deal to drive growth post-2028, UBS says - Investing.com Canada

Bayer Sues Biontech and Pfizer Over Patents for Covid Vaccines - MarketScreener

Pfizer: 2026 Guidance Points To Continued Margin And Growth Pressure (NYSE:PFE) - Seeking Alpha

Bayer Targets Pfizer, Moderna, J&J For Covid Jab Royalties - Law360

Bayer sues COVID vaccine makers over mRNA technology - Reuters

December Social Media Round-Up—2025 Highlights, YaoPharma Co., Ltd. Global Collaboration, and More - Pfizer

Is Pfizer (PFE) Offering Value After Recent Share Price Weakness? - Yahoo Finance

Pfizer Stock Plot Twist: Is This Big Pharma OG a Secret Comeback Play or Total Trap? - AD HOC NEWS

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Pfizer invested in this Peninsula biotech startup. Now they've cut a potentially big drug deal - The Business Journals

Cartography Biosciences And Pfizer To Collaborate On The Discovery Of Tumor-Selective Antigens - TradingView — Track All Markets

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens - Business Wire

Torray Investment Partners LLC Acquires 102,107 Shares of Pfizer Inc. $PFE - MarketBeat

Sulfasalazine Market Is Booming Worldwide 2026-2033 | Pfizer - openPR.com

Robeco Institutional Asset Management B.V. Has $290.44 Million Holdings in Pfizer Inc. $PFE - MarketBeat

Phenobarbital Market See Incredible Growth 2025-2032 | Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S - openPR.com

Pfizer's Quarterly Earnings Preview: What You Need to Know - Barchart.com

Gateway Investment Advisers LLC Lowers Stock Position in Pfizer Inc. $PFE - MarketBeat

Sleep Aids Market Booming with Rapid Growth Through 2033| Pfizer Inc., GSK plc, Sommetrics, Inc. - openPR.com

Pfizer’s 2026 Drug Price Reset Could Be A Game Changer For Pfizer (PFE) - simplywall.st

Pfizer (PFE) Stock: COVID-19 Revenue Decline Spurs Strategic Shift - parameter.io

Pfizer Inc. $PFE Position Cut by Commonwealth Equity Services LLC - MarketBeat

Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals - Finviz

Assessing Pfizer (PFE) Valuation After Recent Share Price Weakness And Dividend Support - Yahoo Finance

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference - Bluefield Daily Telegraph

Better dividend stock: Ford vs. Pfizer - MSN

D.A. Davidson & CO. Acquires 70,161 Shares of Pfizer Inc. $PFE - MarketBeat

Better Dividend Stock: Ford vs. Pfizer - Finviz

Daymark Wealth Partners LLC Sells 52,529 Shares of Pfizer Inc. $PFE - MarketBeat

Pfizer Inc. $PFE Shares Sold by Allen Wealth Management LLC - MarketBeat

Asset Management One Co. Ltd. Grows Position in Pfizer Inc. $PFE - MarketBeat

Capital Advisors Inc. OK Grows Stake in Pfizer Inc. $PFE - MarketBeat

Pfizer Inc Is On Clearance?! The Wild Truth Behind PFE’s Price Drop - AD HOC NEWS

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom - ts2.tech

Pfizer Ltd Is Having a Moment: Hype Stock or Just Hot Air? - AD HOC NEWS

Pfizer Inc. $PFE Shares Purchased by Verity & Verity LLC - MarketBeat

How Safe Is Pfizer's Dividend As 2026 Begins? - The Globe and Mail

GILD

$120.67

2.96%

SNY

$48.13

0.50%

AMGN

$330.11

3.37%

NVO

$57.34

1.36%

NVS

$141.46

0.37%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters